Clinical Trial Update: Gemcitabine, Bevacizumab, and Abdominal Radiation Therapy in Treating Patients With Localized Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine, bevacizumab, and abdominal radiation therapy in localized pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Northwestern University | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED